Schiffler P, Tenberge J, Wiendl H, Meuth SG. Cortex Parcellation Associated Whole White Matter Parcellation in Individual Subjects.Front Hum Neurosci. 2017 Jul 6;11:352.
Krämer J, Tenberge J-G, Kleiter I, Gaissmaier W, Ruck T, Heesen C, Meuth SG. Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis? PLoS ONE 2017 2017 Apr 13;12(4):e0174858.
Deppe M, Tabelow K, Krämer J, Tenberge J, Schiffler P, Bittner S, Schwindt W, Zipp F, Wiendl H, Meuth SG. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration Multiple Sclerosis 2016 Jan;22(1):73-84.
Deppe M., Krämer J., Tenberge J., Marinell J., Schwindt W., Deppe K., Groppa S., Wiendl H., Meuth S. Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis. Hum Brain Mapp. 2016 May;37(5):1866-79.
Lenders M, Canaan-Kuehl S, Kraemer J, Duning T, Reiermann S, Sommer C, Stypmann J, Blaschke D, Ueceyler N, Hense H, Brand S, Wanner C, Weidemann F, Brand E (2016) Fabry patients after enzyme replacement therapy dose reduction and treatment switch: Renal impairment after 24 months follow-up. Molecular Genetics and Metabolism 2016 Feb; 117(2):72-73.
Krämer J, Meuth SG, Tenberge J, Schiffler P, Wiendl H, Deppe M. Early and degressive putamen atrophy in multiple sclerosis. Int J Mol Sci. 2015 Sep 25;16(10):23195-209.
Teuber A, Tenberge J, Kugel H, Deppe M, Berger K, Wersching H. Volume transition analysis: A new approach to resolve reclassification of brain tissue in repeated MRI scans. J Neurosci Methods. 2015 Mar 30;243:78-83.
Kraemer J, Deppe M, Goebel K, Tabelow K, Wiendl H, Meuth SG. Recovery of thalamic microstructural damage after Shiga toxin 2-associated hemolytic uremic-syndrome.J Neurol Sci. 2015 Sep 15;356(1-2):175-83.